InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,576.98
(
0.07%
)
US TECH 100
19,910.80
(
0.00%
)
Dow Jones
39,291.97
(
-0.13%
)
Brent Oil
83.85
(
-1.00%
)
Bitcoin
59,030.68
(
1.74%
)
Post# of 252545
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 831
Posts 120010
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: spartex post# 25632

Tuesday, 03/14/2006 11:05:23 AM

Tuesday, March 14, 2006 11:05:23 AM

Post# of 252545
For an ADPC indication they would presumably have to run at least one more large clinical trial in that setting. As such a trial has not yet been designed, two years to approval is out of the question. You are probably talking about four years, minimum. And that’s assuming it is worth pursuing at all, which depends on the P-11 data. Regards, Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up